SCI Logo
 

The Society of Chemical Industry

Username:
Password:

 
 
Click here to go to the Chemistry & Industry web site
 
Click here to go to The SupplyLine web site
 
Click here to go to the Journal of the Science of Food and Agriculture web site
 
Click here to go to the Polymer International web site
 
Click here to go to the Pest Management Science web site
 
Click here to go to the Journal of Chemical Technology and Biotechnology web site
 
Click here to go to the Biofuels, Bioproducts and Biorefining (Biofpr) web site
 
 

Search SCI

Advance Search


Related Links

Chemistry & Industry

C&I in the news

Comment on this article



Biology for Chemists

23- 24 June 2008

Biology for Chemists



Chemistry & IndustryNew formula for fit future


Baby food offering lifetime protection against obesity could be in the supermarket soon, Lisa Melton reports

milkUK researchers are developing infant formula and other ‘child-friendly’ preparations that will provide permanent protection from obesity and diabetes into adulthood, even in those individuals on high-fat diets.

The foods will be supplemented with leptin, which will help keep those who take the new products early in life permanently slim. ‘Like those people who are lean by nature even though they over-eat -- like we all do – they will tend to be inefficient in terms of using energy,’ said Mike Cawthorne, who heads the Metabolic Research team at the Clore Laboratory in the University of Buckingham, UK.

The Buckingham team has already shown that giving rats leptin supplements early in life offers permanent protection against obesity and diabetes in adulthood (AM J Physiol Regul Integr Comp Physiol, doi: 10.1152/ajpregu.00676.2006). Even animals fed a high-fat diet remained slim.

Leptin is best known as the fat hormone that turns off hunger in the brain. It is naturally produced throughout life. But leptin’s role in infancy is slightly different: it hardwires the body’s energy balance settings. In fact, the decision to be fat or thin may even be made before birth, during pregnancy. Feeding the hormone to pregnant rodents has a lifelong impact on their offspring’s predisposition to obesity. Animals born of leptin-treated mothers remain lean even when fed a fat-laden diet, while those from untreated rodents gained weight and developed diabetes.

The difference boils down to energy expenditure, Cawthorne has found. The offspring of leptin-treated mothers burn up more energy. ‘The infants are permanently inefficient in terms of using energy,’ said Cawthorne who envisages giving leptin supplements to infants to protect them against future weight gain.

Leptin-enriched foodstuffs could soon be sitting in our shopping trolleys or available at pharmacies, he said. Cawthorne is planning the development of infant milks and other products. ‘The supplemented milks are simply adding back something that was originally present: breast milk contains leptin and formula feeds don’t,’ he said.

But previous experiments with leptin failed when treated individuals seemed to resist its hunger-quenching effect. Cawthorne believes that, this time, the physiological circumstances could be right. ‘You would only take this for a short time, very early in life,’ he pointed out.

As worldwide obesity rates continue to escalate, a treatment that stops weight gain could not come too soon. And it is not just humans that stand to gain. ‘One must also remember the pet market. Fat and diabetic cats and dogs are a major problem today,’ Cawthorne added.

But Edinburgh researcher Jonathan Seckl said that although the science is very promising, we will need to be patient. ‘We need to know whether leptin is acting pre- and post-natally, figure out how it works, and dissect the possible side-effects before this becomes a potential approach for humans. Nonetheless, this is good science,’ he said. .